Available soon in the US

Where sound meets design

The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Oticon Medical’s Neuro System to treat individuals over 18 years, with bilateral severe-to-profound sensorineural hearing loss1, who obtain limited benefit from appropriately fitted hearing aid(s). The innovative cochlear implant system delivers premium sound quality, award-winning aesthetic design and is designed for outstanding reliability.   

 

Yes, I would like to know more about the Neuro System!

Cochlear implants can change your hearing

A cochlear implant is an electronic medical device for people with severe-to-profound hearing loss1. It works by transforming sounds into electrical signals that are sent straight to the auditory nerve. This means that it can bypass the damaged areas of the ear. 

Only your doctor and audiologist can determine whether you are a candidate for a cochlear implant.

If you suffer from severe hearing loss, a cochlear implant may be able to help you

Enjoy life with a level of hearing that you only ever dreamt of

If you have severe hearing loss, a cochlear implant may be able to help you to:

  • better understand speech
  • watch television and listen to music
  • use the phone 
  • take part in social situations

How cochlear implants work


Conventional hearing aids capture sound, amplify it, and send it through the normal auditory channel. However, if your ear is too severely damaged, amplifying sound in this way will have no effect. The cochlear implant overcomes this by sending the signal directly to the auditory nerve. This means that unlike conventional hearing aids, cochlear implants bypass the damaged areas of the ear. They capture the sound, process it, and electronically stimulate the auditory nerve.

Meet Juul - a Neuro System user

At the age of 30, Juul from The Netherlands, suddenly became bilaterally deaf. She was quickly assisted with the Neuro Zti implant and the Neuro sound processor.2

Meet Michele - a Neuro System user

For Michele music has always been important throughout his life. With the Neuro sound processor he has gotten this joy back. Listen to his story and what he experienced.2

 

Reliable and robust

Quality you can rely on

The Neuro System has undergone the most extensive design and testing programs and has the highest classification in cochlear implants against water and dust, the IP68. Whatever the weather or situation, it delivers the hearing clarity you rely on.

Download the 2020 Reliability Report

Oticon Medical

A safe and proven choice for hearing

When you choose a cochlear implant, you choose a hearing partner for life. Oticon Medical is a global company in implantable hearing solutions and part of the Demant Group - one of the world’s leading hearing healthcare companies. At Oticon Medical we combine the latest advancements in hearing instruments with three decades of expertise in cochlear implants.

Read more about Oticon Medical

 

 

 

Would you like more information about Oticon Medical’s Neuro System and how to get it when it becomes available in US hospitals and clinics? Fill out the form and you will be contacted as soon as possible.


By clicking ’submit’ I agree that Oticon Medical can contact me by e-mail or phone to respond to my request, and I also agree that Oticon Medical may send me e-mails with news and information regarding Oticon Medical’s products and services.

The consent to receive e-mails can easily be revoked by clicking the ‘unsubscribe’ link found in each e-mail from Oticon Medical.

Oticon Medical respects the privacy of visitors using this website and will not share your information with anyone. Read our Privacy Policy.


 

 

1. Severe-to-profound hearing loss is determined by a pure-tone average (PTA) superior or equal (≥) to 70 dB HL at 500, 1000 and 2000 Hz. Limited benefit from amplification is defined by scores of 50% or less on Hearing in Noise Test (HINT) sentences in quiet or noise, in the best-aided listening condition. Unless already appropriately fitted with hearing aids, it is recommended that candidates undergo a hearing aid trial period of three (3) months.

2. Not all hearing loss patients are candidates for a cochlear implant. All surgical procedures include an element of risk, and it is impossible to guarantee success. Outcomes may vary. Results from case studies may not be predictive of results in other cases.